Journal of Cutaneous Medicine and Surgery
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort Study.
2024
-
Comparison of Dermatologists' and Nondermatologists' Diagnostic Accuracy for Malignant Melanoma
2012
-
A Cross-Sectional Analysis of Psoriasis Patient Experiences on YouTube and TikTok..
12034754251316293.
2025
-
Characteristics of Patients With Adult-Onset Dermatomyositis at 2 Tertiary Care Centres in Ontario, Canada..
29:124-130.
2025
-
Machine Learning Applications in Hidradenitis Suppurativa Diagnosis, Management, and Severity Assessment: A Systematic Review..
12034754241303091.
2024
-
Applications of Machine Learning on Alopecia Areata: A Systematic Review.
28:303-304.
2024
-
Machine Learning Applications in Psoriasis Treatment: A Systematic Review.
28:301-302.
2024
-
Association Between Parkinson’s Disease and Psoriasis: A Scoping Review.
28:72-73.
2024
-
Evaluation of Vision LLMs GTP-4V and LLaVA for the Recognition of Features Characteristic of Melanoma.
28:98-99.
2024
-
GLP-1R Agonists in Psoriasis Patients.
28:91-92.
2024
-
Management of Guttate Psoriasis: A Systematic Review.
28:577-584.
2024
-
Use of Janus Kinase Inhibitor Treatment for Palmoplantar Pustulosis: An Evidence-Based Review.
28:86-87.
2024
-
Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
27:594-600.
2023
-
A Systematic Review and Meta-Analysis of Injection Site Reactions in Randomized-Controlled Trials of Biologic Injections.
27:358-367.
2023
-
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway.
27:3S-24S.
2023
-
Under-Reporting of COVID-19 Infections in Psoriasis Patients on Biologics.
27:75-76.
2023
-
Review and Practical Guidance on Managing Fungal Infections in Patients With Psoriasis Receiving Anti-IL-17 Therapies.
26:3S-23S.
2022
-
Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers.
26:267-273.
2022
-
Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study.
26:319-320.
2022
-
A Useful Clinical Tool for Psoriasis.
25:648-649.
2021
-
A Psoriatic Patient-Based Survey on the Understanding of the Use of Vaccines While on Biologics During the COVID-19 Pandemic.
25:298-302.
2021
-
Retrospective Study of Patients With SJS/TEN Treated at a Tertiary Burn Unit in Canada: Overview of 17 Years of Treatment.
25:271-280.
2021
-
Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns.
25:169-176.
2021
-
A Review of Drug-Drug Interactions for Biologic Drugs Used in the Treatment of Psoriasis.
25:38-44.
2021
-
The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Meta-Analysis.
24:601-607.
2020
-
Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper.
24:3S-14S.
2020
-
Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice.
24:418-419.
2020
-
Canadian Burden of Skin Disease From 1990 to 2017: Results From the Global Burden of Disease 2017 Study.
24:161-173.
2020
-
Is Access to Care Associated With Stage at Presentation and Survival for Melanoma Patients?.
23:586-594.
2019
-
The Role of IL-17 in Papulopustular Rosacea and Future Directions.
23:635-641.
2019
-
Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis.
23:391-393.
2019
-
Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study.
23:282-288.
2019
-
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.
23:50-74.
2019
-
Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys.
22:464-471.
2018
-
Sunnybrook Protocol for Treatment of Toxic Epidermal Necrolysis.
22:535-535.
2018
-
Toxic Epidermal Necrolysis Spectrum Management at Sunnybrook Health Sciences Centre: Our Multidisciplinary Approach After Review of the Current Evidence.
22:213-219.
2018
-
A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults.
22:78-83.
2018
-
Undergraduate Dermatology Education in Canada: A National Survey.
22:31-37.
2018
-
Acitretin Use in Dermatology.
21:2S-12S.
2017
-
Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.
21:2S-40S.
2017
-
An Open Letter to Health Canada.
21:195-196.
2017
-
Review of Systemic Treatment Options for Adult Atopic Dermatitis.
21:31-39.
2017
-
2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009.
20:375-431.
2016
-
Acral Hemorrhagic Darier’s Disease.
20:478-480.
2016
-
Psoronychomycosis.
20:279-280.
2016
-
Borderline Lepromatous Leprosy.
20:176-177.
2016
-
Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer (vol 19, pg 216, 2015).
19:604-604.
2015
-
Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses (vol 19, 227, 2015).
19:604-604.
2015
-
The Relationship Between Dermatologist- and Patient-Reported Acne Severity Measures and Treatment Recommendations.
19:464-469.
2015
-
Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines.
19:205-215.
2015
-
Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer.
19:216-226.
2015
-
Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.
19:227-238.
2015
-
Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma.
19:239-248.
2015
-
Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma.
19:249-259.
2015
-
Paradoxical, Cupping-Induced Localized Psoriasis: A Koebner Phenomenon.
19:320-322.
2015
-
Public Engagement with Dermatology Contents on Facebook.
19:304-308.
2015
-
Recall Dermatitis to Metronidazole.
19:326-327.
2015
-
Think beyond the Skin.
19:22-27.
2015
-
Use of Facebook as a Tool for Knowledge Dissemination in Dermatology.
18:341-344.
2014
-
A Consensus on Acne Management Focused on Specific Patient Features.
18:243-255.
2014
-
Unilateral Hand Allergic Contact Dermatitis due to Occupational Exposure.
18:283-286.
2014
-
Surface Anatomy of the Ear.
18:137-140.
2014
-
Clinical features of external genital warts..
17 Suppl 2:S55-S60.
2013
-
Managing external genital warts: practical aspects of treatment and prevention..
17 Suppl 2:S68-S75.
2013
-
Therapeutic options for external genital warts..
17 Suppl 2:S61-S67.
2013
-
Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus..
17 Suppl 2:S47-S54.
2013
-
One-Year, Multicenter, Open-Label, Single-Arm Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Moderate-to-Severe Plaque Psoriasis in a Canadian Population.
17:129-138.
2013
-
Sulfa or Sulfur? Clearing Things up.
17:79-81.
2013
-
Surface Anatomy of the Nose for the Dermatologist.
17:143-146.
2013
-
Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice.
16:407-416.
2012
-
Comparison of Dermatologists' and Nondermatologists' Diagnostic Accuracy for Malignant Melanoma.
16:272-280.
2012
-
Unilateral Keratoderma in a Mother and Her Son.
16:288-290.
2012
-
Impact of the Number of Dermatologists on Dermatology Biomedical Research: A Canadian Study.
16:174-179.
2012
-
Sweet Syndrome and Pemphigus Vulgaris.
16:128-130.
2012
-
Figurate Erythema: An Unusual Presentation of the Nonbullous Phase of Bullous Pemphigoid.
16:61-63.
2012
-
Figurate Erythema: An Unusual Presentation of the Nonbullous Phase of Bullous Pemphigoid.
16:61-63.
2012
-
Impact of the number of dermatologists on dermatology biomedical research: a Canadian study..
16:174-179.
2012
-
Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations.
15:309-321.
2011
-
Canadian Guidelines for the Management of Plaque Psoriasis: Overview.
15:210-219.
2011
-
Gourmet Clinical Pearls.
15:63-64.
2011
-
Drug-Induced Lichenoid Dermatitis with Histopathologic Features of Mycosis Fungoides in a Patient with Psoriasis.
14:307-309.
2010
-
Antepartum Intravenous Immunoglobulin Therapy in Refractory Pemphigoid Gestationis: Case Report and Literature Review.
14:189-192.
2010
-
Development and Validation of a Scale for Acne Scar Severity (SCAR-S) of the Face and Trunk.
14:156-160.
2010
-
Are Excipients Really Inert Ingredients? A Review of Adverse Reactions to Excipients in Oral Dermatologic Medications in Canada.
14:105-114.
2010
-
Efficacy Outcomes in Patients Using Alefacept in the AWARE Study.
13:S122-S130.
2009
-
Adalimumab in the Treatment of Psoriasis: Pooled Efficacy and Safety Results from Three Pivotal Studies.
13:S58-S66.
2009
-
Effect of Quality of Life Impact and Clinical Severity on Adherence to Topical Acne Treatment.
13:204-208.
2009
-
Skin Thickening in a Hemodialysis Patient: A Case of Nephrogenic Fibrosing Dermopathy.
13:110-114.
2009
-
Nail Psoriasis and Biologics.
13:1-5.
2009
-
Occurrence of Plantar Pustular Psoriasis during Treatment with Infliximab.
13:40-42.
2009
-
Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics.
12:282-287.
2008
-
Psychopharmacology in Psychodermatology.
12:255-267.
2008
-
Are All Seborrheic Keratoses Benign? Review of the Typical Lesion and Its Variants.
12:203-210.
2008
-
Divergence of Demographic Factors Associated with Clinical Severity Compared with Quality of Life Impact in Acne.
12:235-242.
2008
-
Development and Validation of a Comprehensive Acne Severity Scale.
11:211-216.
2007
-
Miliarial Gout (A New Entity).
11:31-34.
2007
-
Multitherapy Approach to Onychomycosis Therapy.
10:S44-S47.
2006
-
Prevalence and Epidemiology of Onychomycosis.
10:S28-S33.
2006
-
Cutaneous Reaction to Drugs Used for Erectile Dysfunction: Case Report and Review of the Literature.
10:128-130.
2006
-
Antihistamines in the Treatment of Atopic Dermatitis.
7:467-473.
2003
-
Antihistamines in the Treatment of Atopic Dermatitis.
7:467-473.
2003
-
When Is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant?.
7:387-389.
2003
-
When is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant?.
7:387-389.
2003
-
Mycophenolate Mofetil (CellCept�) for Psoriasis: A Two-Center, Prospective, Open-Label Clinical Trial.
7:193-197.
2003
-
Treatment of Self-Mutilation with Olanzapine.
4:160-162.
2000
-
Treatment of self-mutilation with olanzapine..
4:161-163.
2000
-
Monetary and Nonmonetary Costs to Patients Attending an Ambulatory Dermatology Clinic.
3:188-192.
1999
-
Role of the Cyclin-Dependent Kinase Inhibitor CDKN2A in Familial Melanoma.
2:172-179.
1998
-
The future of surgical versus medical dermatology.
1:216-218.
1997
-
Current Thoughts on the Use of Methotrexate in Patients with Psoriasis.
2:41-46.
1997
-
Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice.
16:407-416.
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)